Clinical Trial Update: RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RCHOP chemotherapy with BBB permeabilization by t-NGR necrosis factor in diffuse large B-cell lymphoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• RCHOP (rituximab cyclophosphamide doxorubicin vincristine prednisone)

Snippet

Sponsor: Andres J. M. Ferreri | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 2 | Status: COMPLETED